Citigroup’s Verona Pharma VRNA Stock Holding History

Citigroup’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-500	Closed	-$47.3K	–	6344
2025 Q2	$47.3K	Buy	+500	New	+$37K	﹤0.01%	4789

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Citigroup's VRNA Position: Q4 2025 in Review

Citigroup sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 231,508 shares — an estimated $24.7M sold.

Citigroup first reported a position in VRNA in Q3 2021 and held it in 14 quarters. The position peaked at $24.7M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Citigroup reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Citigroup sold 231,508 Verona Pharma shares in Q4 2025, an estimated $24.7M.
Citigroup first reported a position in Verona Pharma in Q3 2021 and held it in 14 quarters.
Citigroup's Verona Pharma position peaked at $24.7M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.